𝔖 Bobbio Scriptorium

✦ LIBER ✦

Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™) following primary series administration at 2, 4, 6 months of age in Latin America

✍ Scribed by Santos-Lima, Eduardo; B’Chir, Siham; Lane, Andrew

Book ID: 121215723
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 158 KB
Volume: 31
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.11.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety study of a new

Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants

✍ Pope Kosalaraksa; Usa Thisyakorn; Suwat Benjaponpitak; Kulkanya Chokephaibulkit; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Immunogenicity and safety of a primary s

Immunogenicity and safety of a primary series of a new fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine (Hexaxim™) co-administered with Prevenar™ and Rotarix™ in healthy children in Latin America

✍ P. Lopez; A. Arguedas Mohs; M.-C. Miranda; B. Zambrano; E. Santos Lima 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB